Literature DB >> 9973397

T cell epitopes of a lipocalin allergen colocalize with the conserved regions of the molecule.

T Zeiler1, R Mäntyjärvi, J Rautiainen, M Rytkönen-Nissinen, P Vilja, A Taivainen, J Kauppinen, T Virtanen.   

Abstract

In this study we characterized the human T cell-reactive sites of the major cow dander allergen, Bos d 2, a member of the lipocalin protein family. We showed that Bos d 2 contains only a limited number of epitopes. This is in contrast to many other allergens, which usually contain multiple T cell epitopes throughout the molecule. The epitopes of Bos d 2 were primarily concentrated in the conserved regions of the molecule. One of the epitopes was recognized by all the cow-asthmatic individuals regardless of their HLA phenotype. Computer-predicted T cell epitopes on Bos d 2, other lipocalin allergens, and human endogenous lipocalins were situated in similar locations on these molecules and corresponded to experimentally identified epitopes on Bos d 2. The results suggest that human endogenous lipocalins could be involved in the modulation of immune responses against exogenous lipocalin allergens. In addition, our findings are likely to facilitate the development of new forms of immunotherapy against allergies induced by the important group of lipocalin allergens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Recombinant allergens.

Authors:  C Grégoire; M D Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Cross-reactivity of plant and animal allergens.

Authors:  R W Weber
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

3.  Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.

Authors:  Anu K Immonen; Antti H Taivainen; Ale T O Närvänen; Tuure T Kinnunen; Soili A Saarelainen; Marja A Rytkönen-Nissinen; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

4.  Differential CD4+ T-cell responses of allergic and non-allergic subjects to the immunodominant epitope region of the horse major allergen Equ c 1.

Authors:  Anssi Kailaanmäki; Tuure Kinnunen; William W Kwok; Marja Rytkönen-Nissinen; Jukka Randell; Tuomas Virtanen
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

5.  Reply to the letter to the editor concerning the review Immunotherapy for pet allergies.

Authors:  Tuomas Virtanen
Journal:  Hum Vaccin Immunother       Date:  2018-04-11       Impact factor: 3.452

6.  Immunotherapeutic potential of the immunodominant T-cell epitope of lipocalin allergen Bos d 2 and its analogues.

Authors:  Soili A Saarelainen; Tuure T Kinnunen; Cécile Buhot; Ale T O Närvänen; Anu K Kauppinen; Marja A Rytkönen-Nissinen; Bernard Maillere; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-10-16       Impact factor: 7.397

7.  IgE Reactivity of the Dog Lipocalin Allergen Can f 4 and the Development of a Sandwich ELISA for Its Quantification.

Authors:  Marja Rytkönen-Nissinen; Soili Saarelainen; Jukka Randell; Jukka Häyrinen; Nisse Kalkkinen; Tuomas Virtanen
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-05       Impact factor: 5.764

Review 8.  Immune responses to inhalant Mammalian allergens.

Authors:  François Hentges; Cathy Léonard; Karthik Arumugam; Christiane Hilger
Journal:  Front Immunol       Date:  2014-05-21       Impact factor: 7.561

9.  Human CD4+ T cell responses to the dog major allergen Can f 1 and its human homologue tear lipocalin resemble each other.

Authors:  Aino L K Liukko; Tuure T Kinnunen; Marja A Rytkönen-Nissinen; Anssi H T Kailaanmäki; Jukka T Randell; Bernard Maillère; Tuomas I Virtanen
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

10.  In silico analysis of a major allergen from Rattus norvegicus, Rat n 1, and cross-reactivity with domestic pets.

Authors:  Marlon Munera; Neyder Contreras; Andres Sánchez; Jorge Sánchez; Yuliana Emiliani
Journal:  F1000Res       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.